Author:
Lochmann van Bennekom Marc W.H.,IntHout Joanna,Gijsman Harm J.,Akdede Berna B.K.,Yağcıoğlu A. Elif Anıl,Barnes Thomas R.E.,Galling Britta,Gueorguieva Ralitza,Kasper Siegfried,Kreinin Anatoly,Nielsen Jimmi,Nielsen René Ernst,Remington Gary,Repo-Tiihonen Eila,Schmidt-Kraepelin Christian,Shafti Saeed S.,Xiao Le,Correll Christoph U.,Verkes Robbert-Jan
Reference57 articles.
1. A survey study on clinicians’ rationale and attitude towards the prescription of antipsychotic polypharmacy in the East Perth metropolitan area in Western Australia;Ajayi;Cureus,2023
2. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition;Akdede;J. Clin. Psychiatry,2006
3. The American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia;American Psychiatric Association,2020
4. Methods for assessing positive and negative symptoms;Andreasen;Mod. Probl. Pharmacopsychiatry,1990
5. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety;Anil Yagcioglu;J. Clin. Psychiatry,2005